Althea Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Althea Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $2.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Althea Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $2.4M Trade | TransData Nexus

Althea Pharma Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $2.4M Total Trade · DGFT Verified

Althea Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.4M across 3 products in 1 therapeutic categories. Based on 602 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Salbutamol ($1.2M), Ipratropium ($685.5K), Budesonide ($578.6K).

Althea Pharma Private Limited — Export Portfolio & Destination Treemap

Althea Pharma Private Limited pharmaceutical export portfolio — 3 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Althea Pharma Private Limited? — Company Overview & Market Position

Althea Pharma Private Limited, established on May 27, 2004, is a privately held pharmaceutical company headquartered in Vapi, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24232GJ2004PTC044200. As of the latest available data, Althea Pharma has an authorized capital of ₹5.00 crore and a paid-up capital of ₹68.78 lakh. The company is unlisted and operates as a non-government entity. Its registered office is located at Room No. 403, Al-Husan Place, Godal Nagar, Vapi, Gujarat, 396191, India.

Althea Pharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is concentrated in the respiratory therapeutic category, with a focus on inhalants such as Salbutamol, Ipratropium, and Budesonide. In the fiscal year 2022, Althea Pharma reported a total export value of $2.4 million USD, comprising 602 shipments. The top three exported products were Salbutamol ($1.2 million, 0.8% market share), Ipratropium ($686,000, 1.2% market share), and Budesonide ($579,000, 0.3% market share). Notably, the company's portfolio is highly concentrated, with the top five products accounting for 100% of its exports.

What Does Althea Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Salbutamol

Product Portfolio — Top 3 by Export Value

Althea Pharma Private Limited exports 3 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Salbutamol	Respiratory	$1.2M	309	0.8%	12
2	Ipratropium	Respiratory	$685.5K	174	1.2%	4
3	Budesonide	Respiratory	$578.6K	119	0.3%	9

Althea Pharma Private Limited exports 3 pharmaceutical products across 1 therapeutic categories with a total export value of $2.4M. The top category is Respiratory (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Althea Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Althea Pharma operates manufacturing facilities in Daman, India. The factory is situated at 374, Shed 'E', Alpha Industrial Park, Athiawad, Dabhel, Nani Daman, Daman, 396 210 (UT), India. The facility specializes in the production of intravenous (IV) fluids using Form-Fill-Seal (FFS) technology. The company is also planning to expand its manufacturing capabilities to include sterile IV drugs in glass ampoules and vials. Althea Pharma holds WHO-GMP certification and has obtained approvals from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen.

3Key Leadership

Althea Pharma is led by directors Vaibhav Purnandu Jain and Aakanksha Purnandu Jain. Vaibhav Purnandu Jain has been serving as a director since June 23, 2014, while Aakanksha Purnandu Jain joined the board on October 16, 2017. The company's leadership is characterized by a dynamic and forward-looking approach, with a focus on transitioning from a volume-based to a value-based business model.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Althea Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Althea Pharma has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained WHO-GMP certification, which is recognized by regulatory authorities in these regions. Additionally, Althea Pharma holds certifications from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen, indicating compliance with international quality standards. While specific regulatory filings and approvals in the U.S., EU, UK, Australia, and Japan are not detailed in the available sources, the company's adherence to WHO-GMP standards suggests a commitment to meeting the requirements of these markets.

2Emerging Markets

Althea Pharma has expanded its reach into emerging markets, including Africa, Latin America, and Southeast Asia. The company's WHO-GMP certification facilitates access to these regions, as it is recognized by regulatory authorities in many countries. By obtaining approvals from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen, Althea Pharma demonstrates its commitment to meeting international quality standards and regulatory requirements in emerging markets.

3Geographic Strategy

Althea Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Althea Pharma's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not available in the provided sources. The company's WHO-GMP certification indicates compliance with international manufacturing standards, which is a prerequisite for FDA approvals. However, without detailed records, it is challenging to assess the company's standing with the FDA.

2WHO & EU GMP

Althea Pharma holds WHO-GMP certification, demonstrating compliance with international manufacturing standards. This certification is recognized by regulatory authorities in the European Union, facilitating market access. The company's adherence to WHO-GMP standards underscores its commitment to maintaining high-quality manufacturing processes.

3CDSCO & Indian Regulatory

Specific details regarding Althea Pharma's manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), state drug controller approvals, and export No Objection Certificates (NOCs) are not available in the provided sources. The company's WHO-GMP certification and certifications from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen suggest compliance with international regulatory standards. However, without explicit information on CDSCO approvals and export NOCs, it is difficult to assess the company's regulatory standing within India.

Althea Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Althea Pharma operates in the competitive pharmaceutical industry, focusing on the respiratory therapeutic category. While specific competitors in overlapping categories are not detailed in the available sources, the company's emphasis on high-quality manufacturing and adherence to international standards positions it favorably in the market. The concentration of its export portfolio on a few products may limit its market share in broader therapeutic categories. Expanding its product range and exploring new therapeutic areas could enhance its competitive position.

2Key Differentiators

Althea Pharma's key differentiators include its adherence to WHO-GMP standards, certifications from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen, and its focus on high-quality manufacturing processes. These factors underscore the company's commitment to delivering products that meet international quality standards. Additionally, the company's strategic location in India provides access to a robust pharmaceutical manufacturing ecosystem.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Althea Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Althea Pharma's track record in manufacturing high-quality pharmaceutical formulations is supported by its WHO-GMP certification and approvals from the National Drug Authority (NDA) of Uganda and the Ministry of Health (MOH) of Yemen. The company's export volume of $2.4 million USD across 602 shipments in 2022 reflects a consistent supply chain performance. However, the high concentration of its export portfolio on a few products suggests a need for diversification to enhance reliability and reduce potential supply chain risks.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Indicates adherence to international manufacturing standards.

National Drug Authority (NDA) Certification: Validates compliance with regulatory requirements in specific countries.

Frequently Asked Questions — Althea Pharma Private Limited

How many pharmaceutical products does Althea Pharma Private Limited export from India?

Althea Pharma Private Limited exports 3 pharmaceutical products across 1 therapeutic categories. The top exports are Salbutamol ($1.2M), Ipratropium ($685.5K), Budesonide ($578.6K). Total export value is $2.4M.

What is Althea Pharma Private Limited's total pharmaceutical export value?

Althea Pharma Private Limited's total pharmaceutical export value is $2.4M, based on 602 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Althea Pharma Private Limited cover?

Althea Pharma Private Limited exports across 1 therapeutic categories. The largest are Respiratory (100.0%, 3 products).

Get Full Althea Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.